Journal article
Hemolytic Anemia Following Succimer Administration in a Glucose-6-Phosphate Dehydrogenase Deficient Patient
Clinical toxicology (Philadelphia, Pa.), Vol.32(5), pp.569-575
1994
DOI: 10.3109/15563659409011061
PMID: 7932916
Abstract
Abstract
Because of its favorable side effects profile, the oral chelating agent dimercaptosuccinic acid is often used for treatment of lead intoxication. We report a case of a 45-year-old black male with glucose-6-phosphate dehydrogenase deficiency and a 17 year history of occupational lead exposure who developed hemolysis during treatment with dimercaptosuccinic acid for symptomatic lead intoxication.
Details
- Title: Subtitle
- Hemolytic Anemia Following Succimer Administration in a Glucose-6-Phosphate Dehydrogenase Deficient Patient
- Creators
- Fredric Gerr - Emory UniversityHoward Frumkin - Emory UniversityPaul Hodgins - Emory University
- Resource Type
- Journal article
- Publication Details
- Clinical toxicology (Philadelphia, Pa.), Vol.32(5), pp.569-575
- Publisher
- Informa UK Ltd
- DOI
- 10.3109/15563659409011061
- PMID
- 7932916
- ISSN
- 1556-3650
- eISSN
- 1556-9519
- Language
- English
- Date published
- 1994
- Academic Unit
- Occupational and Environmental Health; Epidemiology
- Record Identifier
- 9984364436602771
Metrics
10 Record Views